CSF1R and neoplasm: Studies conducted by Pyonteck et al. using a brain-penetrant inhibitor of colony-stimulating factor 1 receptor (CSF-1R) showed a significant decrease in pro-tumourigenic tumour-associated macrophages [106], suggesting that blocking CSF-1R signalling may re-educate the immunosuppressive macrophage to pro-inflammatory cells.